Zantac 75 Efferdose

Company
GlaxoSmithKline

Approval Status
Approved March 1998

Treatment for
heartburn

Areas
Gastrointestinal

Zantac 75 Efferdose has been approved for the treatment of heartburn. It is the first over-the-counter effervescent H2 antagonist.

Zantac_75_efferdose Drug Information

The Zantac_75_efferdose drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top